Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer.

Bjerre MT, Strand SH, Nørgaard M, Kristensen H, Rasmussen AK, Mortensen MM, Fredsøe J, Mouritzen P, Ulhøi B, Ørntoft T, Borre M, Sørensen KD

Open source

DOI
10.3390/ijms20051173
Published
2019 Mar 7
Container
International journal of molecular sciences
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms20051173,
  title = {Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer.},
  author = {Bjerre MT and Strand SH and Nørgaard M and Kristensen H and Rasmussen AK and Mortensen MM and Fredsøe J and Mouritzen P and Ulhøi B and Ørntoft T and Borre M and Sørensen KD},
  year = {2019},
  journal = {International journal of molecular sciences},
  doi = {10.3390/ijms20051173},
  url = {https://doi.org/10.3390/ijms20051173}
}

RIS

TY  - JOUR
TI  - Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer.
AU  - Bjerre MT
AU  - Strand SH
AU  - Nørgaard M
AU  - Kristensen H
AU  - Rasmussen AK
AU  - Mortensen MM
AU  - Fredsøe J
AU  - Mouritzen P
AU  - Ulhøi B
AU  - Ørntoft T
AU  - Borre M
AU  - Sørensen KD
PY  - 2019
JO  - International journal of molecular sciences
DO  - 10.3390/ijms20051173
UR  - https://doi.org/10.3390/ijms20051173
ER  - 

APA

MT, B., SH, S., M, N., H, K., AK, R., MM, M., J, F., P, M., B, U., T, Ø., M, B., & KD, S. (2019). Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer.. International journal of molecular sciences. https://doi.org/10.3390/ijms20051173

Source records